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Abstract 20 
We hypothesized that 4 weeks of dietary nitrate supplementation would enhance exercise 21 
performance and muscle metabolic adaptations to sprint interval training (SIT). Thirty six 22 
recreationally-active subjects, matched on key variables at baseline, completed a series of 23 
exercise tests before and following a 4 week period in which they were allocated to one of the 24 
following groups: 1) SIT and NO3--depleted beetroot juice as a placebo (SIT+PL); 2) SIT and 25 
NO3--rich beetroot juice (~13mmol NO3-/day; SIT+BR); or 3) no training and NO3--rich 26 
beetroot juice (NT+BR). During moderate-intensity exercise, pulmonary Vሶ O2 was reduced by 27 
4% following 4 weeks of SIT+BR and NT+BR (P<0.05) but not SIT+PL. The peak work rate 28 
attained during incremental exercise increased more in SIT+BR than in SIT+PL (P<0.05) or 29 
NT+BR (P<0.001). The reduction in muscle and blood [lactate] and the increase in muscle 30 
pH from pre- to post-intervention was greater at 3 min of severe-intensity exercise in 31 
SIT+BR compared to SIT+PL and NT+BR (P<0.05). However, the change in severe-32 
intensity exercise performance was not different between SIT+BR and SIT+PL (P>0.05). The 33 
relative proportion of type IIx muscle fibers in the m. vastus lateralis was reduced in SIT+BR 34 
only (P<0.05). These findings suggest that BR supplementation may enhance some aspects of 35 
the physiological adaptations to SIT.  36 
New and Noteworthy: We investigated the influence of nitrate-rich and nitrate-depleted 37 
beetroot juice on the muscle metabolic and physiological adaptations to 4 weeks of sprint 38 
interval training. Compared to placebo, dietary nitrate supplementation reduced the O2 cost of 39 
submaximal exercise, resulted in greater improvement in incremental (but not severe-40 
intensity) exercise performance, and augmented some muscle metabolic adaptations to 41 
training. Nitrate supplementation may facilitate some of the physiological responses to sprint 42 
interval training.  43 
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Introduction 47 
The gaseous biological signaling molecule, nitric oxide (NO), is known to modulate several 48 
physiological responses to exercise including skeletal muscle perfusion, energy metabolism 49 
and contractile function (41, 69). Nitric oxide synthase (NOS) enzymes catalyze the oxygen 50 
(O2)-dependent production of NO from L-arginine and it is now known that the products of 51 
NO oxidation, nitrate (NO3-) and nitrite (NO2-), can be reduced in vivo to form NO (52, 72). 52 
Interestingly, hypoxia and acidosis, physiological environments typical of muscular exercise, 53 
facilitate the reduction of NO2- to NO (72). Increasing the dietary intake of inorganic NO3- to 54 
augment circulating NO3- and NO2- pools may therefore represent a natural means to increase 55 
NO bioavailability during exercise.  56 
The physiological effects of NO3- ingestion in humans are well documented and may include 57 
a reduction in blood pressure (BP) at rest and reduced oxygen uptake (Vሶ O2) during sub-58 
maximal exercise (5, 16, 45, 73). Moreover, several studies suggest that NO3- 59 
supplementation can improve performance in a variety of exercise settings, at least in sub-60 
elite athletes (2, 14, 71, 73, 78, cf. 40). It has recently been reported that short-term (3-7 days) 61 
NO3- supplementation may favorably impact the metabolic and contractile properties of 62 
skeletal muscle (30, 46, 76). Specifically, the improvements in exercise efficiency and 63 
performance that have been observed following dietary NO3- supplementation may be related 64 
to altered mitochondrial function (46, cf. 76) and to enhanced muscle force or power 65 
production (19, 30) which, in turn, might be related to increased perfusion and contractile 66 
function (22, 32). It is unclear whether more protracted periods (several weeks) of NO3- 67 
supplementation may more favorably impact the physiological response to exercise and 68 
improve exercise performance. However, given that dietary NO3- may specifically enhance 69 
the physiological responses of type II muscle fibers to exercise (22, 23, 32, 35), and improve 70 
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performance during repeated sprint exercise (2, 71, 78), it is possible that NO3- 71 
supplementation may be of particular value to athletes engaging in high-intensity training.  72 
Sprint interval training (SIT) is known to provide a potent and relatively time-efficient 73 
stimulus for enhancing aerobic capacity and endurance exercise performance (11, 12, 13, 26). 74 
However, the effects of a high-NO3- dietary supplement, such as beetroot juice, consumed 75 
daily as part of an exercise training program, on the physiological and muscle metabolic 76 
adaptations to training has received limited attention (21, 57). It is possible that the NO-77 
mediated inhibition of O2 consumption at cytochrome c oxidase (10, 17) and resultant local 78 
hypoxia may initiate signaling cascades that may be synergistic (or antagonistic) to those 79 
generated by SIT (27). Also, similar to the effects of training, elevated NO bioavailability 80 
may stimulate angiogenesis (25), mitochondrial biogenesis (58) and the transformation of 81 
muscle fiber phenotype (59, 68) through cGMP-dependent gene expression and the activation 82 
of regulatory factors, in particular peroxisome proliferator-activated receptor-gamma 83 
coactivator-1 alpha (PGC-1α; 37, 43). It could also be anticipated that the lower Vሶ O2 and 84 
reduced adenosine triphosphate (ATP) and phosphocreatine (PCr) cost of muscle force 85 
production during high-intensity exercise following NO3- supplementation (6, 24) might 86 
enable a higher training intensity for the same effort which, over time, may lead to greater 87 
training adaptation (34). An increase in cytosolic calcium concentration ([Ca2+]) and force 88 
production during muscle contraction following NO3- supplementation (32) may also permit a 89 
higher training intensity to be maintained. Given the potentially complementary effects of 90 
exercise training and NO bioavailability on metabolic regulation, it is possible that NO3- 91 
supplementation could augment the physiological adaptations to SIT.  92 
Two recent studies have used different approaches to address this question and have 93 
produced somewhat disparate results (21, 57). Muggeridge et al. (57) reported that, compared 94 
to placebo, NO3- supplementation with gels during 3 weeks of SIT (4-6 x 15-s sprints, 3 times 95 
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per week) tended to increase peak work rate during incremental exercise (8.7 vs. 4.7 %; 96 
P=0.07) and reduce the fatigue index during repeated sprint exercise (0.5 vs.7.3 %; P=0.06). 97 
De Smet et al. (21) reported that, compared to placebo, NaNO3 supplementation during 5 98 
weeks of SIT (4-6 x 30-s sprints, 3 times per week), performed in hypoxia, did not improve 99 
either incremental exercise or 30-min time trial performance but did result in a significant 100 
increase in the proportion of type IIa fibers in the m. vastus lateralis. Neither study measured 101 
potential training-related differences in muscle metabolic responses to exercise with NO3- 102 
compared to placebo supplementation (for example, [PCr], pH, [lactate] and [glycogen] as 103 
determined from muscle biopsy) or compared the effects of training with NO3- or placebo to 104 
the physiological effects of NO3- supplementation alone. It would be of interest to determine 105 
whether the intriguing change in muscle fiber type proportions when SIT in hypoxia was 106 
performed with NO3- supplementation (21) is also evident following SIT in normoxia. 107 
Additional studies are clearly required to explore the influence of NO3- supplementation on 108 
the muscle metabolic adaptations and submaximal and maximal exercise responses to 109 
training.   110 
The purpose of this study was therefore to evaluate the independent and combined 111 
performance and physiological effects of SIT and NO3- supplementation during a 4 week 112 
intervention involving: SIT with concurrent NO3--depleted beetroot juice supplementation as 113 
a placebo (PL); SIT with concurrent NO3--rich beetroot juice supplementation (BR); and 114 
NO3--rich beetroot juice supplementation with no training. We tested the hypothesis that 4 115 
weeks SIT and 4 weeks BR supplementation would independently improve physiological 116 
responses and exercise performance, but that these effects would be greater when BR 117 
supplementation and SIT were combined.  118 
  119 
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Methods 120 
Subjects 121 
Eighteen male (mean ± SD: age 27 ± 8 years, height 1.79 ± 0.08 m, body mass 80 ± 13 kg, 122 
Vሶ O2peak 50.4 ± 11.4 mL·kg-1·min-1) and 18 female (mean ± SD: age 23 ± 4 years, height 166 123 
± 5 cm, body mass 65 ± 9 kg, Vሶ O2 peak 39.8 ± 5.8 mL·kg-1·min-1) participants were recruited. 124 
The subjects were recreationally-active sportspeople involved in team and/or endurance 125 
sports but they were not highly trained. Following an explanation of the experimental 126 
procedures, associated risks, potential benefits and likely value of the possible findings, 127 
subjects gave their written informed consent to participate. The study was approved by the 128 
Institutional Research Ethics Committee and conformed to the code of ethics of the 129 
Declaration of Helsinki. 130 
 131 
Experimental Design 132 
Subjects initially visited the laboratory on 3 separate occasions over a 5 day period. On visit 133 
1, subjects performed an incremental exercise test on a cycle ergometer for the determination 134 
of Vሶ O2peak and gas exchange threshold (GET). The work rates requiring 80% of the GET 135 
(moderate exercise) and 85%∆ (GET plus 85% of the difference between the work rate at 136 
GET and Vሶ O2peak; severe exercise) were calculated and adjusted for mean response time for 137 
Vሶ O2 during incremental exercise (75). Following this, subjects were familiarized to the 138 
exercise testing procedures, including completion of a severe-intensity bout of cycle 139 
ergometry until exhaustion. On visit 2, subjects completed a 5-min bout of moderate-intensity 140 
cycling and an incremental exercise test. On visit 3, subjects completed 2 bouts of severe-141 
intensity cycling, the first for 3 min and the second until task failure.  142 
 143 
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In a double-blind, independent-groups design, subjects were then assigned to receive NO3- 144 
rich beetroot juice (BR) or NO3- depleted beetroot juice (PL) for 28 days.  Three independent 145 
groups (n = 12, comprising 6 males and 6 females) were matched at baseline for physical 146 
characteristics (i.e. mass, height and age) as well as physiological and performance variables 147 
of interest, principally BP and peak WR during incremental exercise and secondarily Vሶ O2 peak 148 
and GET. Subjects were then either enrolled onto a 4-week supervised SIT program with PL 149 
(SIT+PL) or BR (SIT+BR) supplementation, or received the NO3--rich beetroot juice for 28 150 
days without undergoing a training intervention (NT+BR).  151 
 152 
All groups completed the same exercise tests (at the same absolute work rates) and 153 
physiological assessments both before and after the 28-day intervention period. Also, after 14 154 
days, subjects visited the laboratory for an incremental exercise test to assess the short-term 155 
changes in aerobic capacity that may be expected following the interventions (11, 65, 73).  156 
 157 
Laboratory visits were scheduled at the same time of day (± 2 h). Subjects were asked to 158 
maintain their normal dietary and exercise behavior throughout the study. However, subjects 159 
were instructed to record their diet during the 24 h preceding the first laboratory visit and to 160 
repeat this for all subsequent laboratory visits. On days of training, subjects were asked to 161 
arrive at the training venue ≥1 h post-prandial and to complete a 5 min self-paced warm up 162 
before training commenced. On experimental days, subjects were instructed to arrive at the 163 
laboratory ≥3 h post-prandial having avoided strenuous exercise and the consumption of 164 
alcohol and caffeine in the 12 h preceding each exercise test. For the duration of the study, 165 
subjects were asked to refrain from taking other dietary supplements, and also to avoid using 166 
antibacterial mouthwash as this inhibits the reduction of NO3- to NO2- in the oral cavity by 167 
eliminating commensal bacteria (29).  168 
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Supplementation 171 
Following the pre-intervention laboratory visits, subjects were allocated to receive 172 
concentrated NO3--rich beetroot juice (BR; beetroot juice; ~6.4 mmol of NO3- per 70 mL; 173 
Beet it, James White Drinks Ltd., Ipswich, UK) or NO3--depleted beetroot juice (PL; placebo 174 
beetroot juice; ~0.04 mmol NO3- per 70 mL; Beet it, James White Drinks Ltd., Ipswich, UK). 175 
Subjects consumed 1 x 70 mL of their allocated supplement each morning and evening for 176 
the duration of the training or non-training intervention and recorded their intake in a diary. 177 
This approach would be expected to result in elevated plasma [NO3-] and [NO2-] for each 24 178 
h period (79). Compliance was checked by the return of empty bottles each week and via 179 
questionnaire at 2 and 4 weeks. BR and PL doses were administered using a double blind 180 
design. On experimental visits at the mid-intervention point and following the intervention 181 
period, subjects consumed 2 x 70 mL of their allocated supplement 2.5 hours prior to the 182 
exercise tests. 183 
 184 
Incremental exercise tests 185 
On the first laboratory visit before and following the intervention period as well as at the mid-186 
intervention point, subjects completed a ramp incremental exercise test on an electronically 187 
braked cycle ergometer (Lode Excalibur Sport, Groningen, Netherlands). The self-selected 188 
cadence (75-90 rpm), saddle and handle bar height and configuration for each subject were 189 
recorded on the first visit and reproduced in subsequent visits. Initially, subjects performed 3 190 
min of baseline cycling at 20 W, after which the work rate was increased by 30 W/min until 191 
the limit of tolerance. Breath-by-breath pulmonary gas exchange data (Oxycon Pro, Jaeger, 192 
Hoechberg, Germany) were collected continuously throughout all incremental tests and were 193 
averaged over 10-s periods. Vሶ O2peak and GET were determined as previously described (73).  194 
 195 
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Step exercise tests 197 
A 5-min moderate-intensity “step” test was performed on the first laboratory visit before and 198 
following the intervention. This was completed 10 min before the ramp incremental test 199 
protocol was initiated. On the second laboratory visit before and following the intervention, 200 
two severe-intensity step tests were performed, separated by a 20 min period of rest; the first 201 
until 3 min, and the second, after 20 min of passive recovery, until task failure. The time to 202 
task failure was recorded once the pedal rate fell by >10 rpm below the target cadence. All 203 
step tests began with 3 min of pedaling at 20 W before a sudden transition to the target work 204 
rate. Muscle biopsies were obtained before and following the 3-min severe intensity exercise 205 
bout and again at task failure in the second bout. Breath-by-breath pulmonary gas exchange 206 
data were collected continuously throughout all step tests. 207 
 208 
Training intervention 209 
Following the initial laboratory visits, subjects were allocated to one of the two SIT groups: 210 
SIT with PL supplementation (SIT+PL; age 25 ± 7 years, height 174 ± 10 cm, body mass 73 211 
± 10 kg); SIT with BR supplementation (SIT+BR; mean ± SD, age 24 ± 7 years, height 174 ± 212 
11 cm, body mass 78 ± 18 kg); or the non-training group with BR supplementation (NT+BR; 213 
age 25 ± 7 years, height 170 ± 6 cm, body mass 68 ± 9 kg). All three groups consisted of 6 214 
male and 6 female subjects. Both SIT groups completed a total of 14 supervised training 215 
sessions over a 4-week period, with at least 24-h separating each training session, while the 216 
NT group maintained their habitual exercise patterns. The post intervention laboratory tests 217 
were performed at least 48h following, but within 4 days of, completing the final training 218 
session. 219 
 220 
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During the training sessions, the SIT groups completed a series of 30-s “all-out” sprints (i.e. 221 
Wingate test) against a resistance equivalent to 7.5% body mass on a mechanically-braked 222 
ergometer (model 814E bicycle ergometer, Monark, Stockholm, Sweden; 11, 12, 13). Each 223 
sprint was separated by a 4-min period of rest in which subjects cycled at a low cadence 224 
against a light resistance to reduce venous pooling and sensations of nausea. During weeks 1 225 
and 2 of training, subjects performed 4 x 30-s sprints three times per week, while during 226 
weeks 3 and 4, subjects performed 5 x 30-s sprints four times per week. Following a 5-min 227 
warm up of cycling against a light resistance, subjects were given a 10-s count down and 228 
instructed to pedal maximally for 2 s before the appropriate load was applied. Subjects were 229 
verbally encouraged to maintain maximal cadence throughout each 30-s sprint. 230 
 231 
Measurements 232 
Blood pressure and heart rate 233 
Before and following the intervention, as well as at the mid-intervention point, the BP at the 234 
brachial artery was measured using an automated sphygmomanometer (Dinamap Pro: GE 235 
Medical Systems, Tampa, FL). Following 10 min seated rest in an isolated room, three 236 
measurements were recorded. MAP was calculated as 1/3 systolic pressure + 2/3 diastolic 237 
pressure. The mean of the systolic, diastolic and MAP measurements were used for data 238 
analysis.  239 
 240 
Blood analysis 241 
Venous blood was sampled at rest (baseline) before each experimental test. Blood samples 242 
were also obtained at 1-min, at 3 min and at exhaustion during the severe-intensity exercise 243 
bout. The blood samples collected during the severe-intensity exercise bout were drawn from 244 
a cannula (Insyte-WTM, Becton Dickinson, Madrid, Spain) inserted into the subject’s 245 
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antecubital vein and were collected into lithium-heparin vacutainers (Becton Dickinson, New 246 
Jersey, USA). Blood [lactate] and [glucose], as well as plasma [NO2-] and [NO3-] were 247 
analyzed in all samples (square brackets denote concentration). 200 μL of blood was 248 
immediately extracted from the lithium-heparin vacutainers and hemolysed in 200 μL of 249 
Triton X-100 solution (Triton X-100, Amresco, Salon, OH) before blood [lactate] and 250 
[glucose] were measured (YSI 2300, Yellow Springs Instruments, Yellow Springs, OH). The 251 
remaining whole blood from each sample was centrifuged at 4000 rpm for 8 min at 4 ºC 252 
within 2 min of collection. Plasma was immediately extracted, frozen at -80 ºC and 253 
subsequently analyzed for [NO2-] and [NO3-] using chemiluminescence, as described by 254 
Wylie et al. (79). 255 
 256 
Muscle biopsy 257 
Muscle samples were obtained from two incisions from the medial region of the m. vastus 258 
lateralis under local anesthesia (1% lidocaine) using the percutaneous Bergström needle 259 
biopsy technique (7) with suction. Muscle samples were taken at three different time points 260 
before and following the intervention: at rest; following 3 min of severe-intensity exercise; 261 
and at task failure from severe-intensity exercise. The post-exercise biopsies were taken 262 
while subjects remained on the cycle ergometer and were typically collected within 5-10 s of 263 
the completion of the exercise bout.  Biopsy samples were immediately frozen in liquid 264 
nitrogen and stored at -80 °C for subsequent analysis.  265 
 266 
Muscle metabolites 267 
Following a freeze-drying process, samples were dissected to remove visible blood, fat, and 268 
connective tissue. Approximately 2 mg aliquots of isolated muscle fibers were weighed on 269 
fine balance scales (Mettler Toledo XS105, Leicester, UK) and stored in 500 µL 270 
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microcentrifuge tubes at -80 °C. Prior to metabolite analysis, 200 µL of 3 M perchloric acid 271 
was added to ~2 mg dry weight muscle tissue. Following 3 min centrifugation and 30 min 272 
incubation on ice, 170 µL of supernatant was transferred to a fresh microcentrifuge tube and 273 
255 µL of cooled 2 M potassium bicarbonate (KHCO3) was added. This was centrifuged, and 274 
the supernatant analyzed for [PCr], [ATP] and [lactate] by fluorometric assays as previously 275 
described (51).  276 
 277 
Muscle glycogen and pH 278 
Glycogen was extracted from ~1 mg d.w. muscle in 500 μL of 1 M hydrochloric acid (HCl) 279 
and hydrolyzed at 100 °C for 2 h to glycosyl units, which were measured using an automated 280 
glucose analyser (YSI 2300, Yellow Springs Instruments, Yellow Springs, OH) to determine 281 
muscle [glycogen]. Muscle pH was measured using a micro-pH meter (Sentron SI600, 282 
Roden, The Netherlands) following homogenization of ~1 mg d.w. muscle in a non-buffering 283 
solution (145 mM KCl, 10 mM NaCl and 5 mM NaF). 284 
 285 
Muscle fiber type 286 
Approximately 20 mg of tissue obtained from each resting muscle biopsy sample was 287 
embedded in Tissue-Tek® O.T.C.™ compound  (Sakura Finetek Europe BV Zoeterwoude, 288 
The Netherlands), rapidly frozen in liquid nitrogen-cooled isopentane, and stored at -80 °C 289 
for subsequent histochemical analysis of myocellular characteristics. Serial cross sections 290 
(~10 μM thick) were cut in a cryostat (Cryostar NX50, Thermo Scientific, USA) maintained 291 
at -16 °C. Sections were mounted on 3 separate slides and pre-incubated at pH values of 4.3, 292 
4.6 and 10.3. According to the lability to the acid and alkaline pre-incubation, the fibers were 293 
stained for myofibrillar ATPase, identified as type I, IIa, or IIx (9) and counted under an 294 
Olympus CKX41 microscope with cellSens Dimension software (Olympus Corporation, 295 
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Tokyo, Japan). For each subject, 214 (± 104) fibers were analyzed, and each fiber type was 296 
expressed as a percentage of the total number counted. 297 
 298 
Oxygen uptake. The breath-by-breath Vሶ O2 data from each step exercise test were initially 299 
examined to exclude values lying more than four SDs from the local mean. The filtered data 300 
were subsequently linearly interpolated to provide second-by-second values and time-aligned 301 
to the start of exercise for each individual. The baseline Vሶ O2 was defined as the mean Vሶ O2 302 
measured over the final 60 s of the 3 min baseline period. The end-exercise Vሶ O2 was defined 303 
as the mean Vሶ O2 measured over the final 60 s of exercise. 304 
 305 
Statistical analyses 306 
Differences between groups in pre-intervention physiological and performance values were 307 
tested using a one way ANOVA. Time by group ANOVAs with repeated measures for time 308 
were employed to determine the physiological and performance effects consequent to the 309 
interventions. In addition, one-way ANOVAs were used to assess differences between groups 310 
in the change values for physiological and performance variables pre- to post-intervention. 311 
All significant main and interaction effects were followed up by Fisher’s LSD post hoc tests. 312 
Data that were not normally distributed were log transformed before applying the ANOVA. 313 
All values are reported as mean ± SD.  Statistical significance was accepted at P<0.05  314 
Results 315 
Compliance 316 
All subjects within the training groups completed 100% of the training sessions and 100% of 317 
the sprints within each training session. All subjects reported that they fully adhered to the 318 
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supplementation regimen and did not alter dietary and exercise behavior outside of their 319 
assigned group-specific intervention.  320 
  321 
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Plasma [NO3-] and [NO2-]  322 
Pre-intervention resting plasma [NO3-] values were not different between groups (P>0.05). A 323 
significant main effect for time (P<0.001) and an interaction effect (P<0.001) was observed 324 
for the plasma [NO3-] measured at rest. Compared to pre-intervention, SIT+BR increased 325 
resting plasma [NO3-] by ~590% at 2 weeks and ~960% at 4 weeks (both P<0.001; Fig. 1A) 326 
and NT+BR increased resting plasma [NO3-] by ~505% at 2 weeks and ~1050% at 4 weeks 327 
(both P<0.001; Fig. 1A) but there was no change in resting plasma [NO3-] with SIT+PL 328 
(P>0.05; Fig. 1A). Resting plasma [NO3-] was also greater at 4 weeks compared to 2 weeks 329 
in both SIT+BR and NT+BR (P<0.05; Fig. 1A). 330 
Pre-intervention resting plasma [NO2-] values were higher in SIT+PL (74 ± 62 nM) compared 331 
to SIT+BR (29 ± 19 nM; P<0.05) and NT+BR (26 ± 13 nM; P<0.05) but were similar 332 
between SIT+BR and NT+BR (P>0.05). There was a significant main effect for time 333 
(P<0.001) and an interaction effect (P<0.001) for the plasma [NO2-] measured at rest. 334 
Compared to pre-intervention, SIT+BR increased resting plasma [NO2-] by ~485% at 2 335 
weeks and ~715% at 4 weeks (both P<0.001; Fig. 1B) and NT+BR increased resting plasma 336 
[NO2-] by ~600% at 2 weeks and ~690% at 4 weeks (both P<0.001; Fig. 1B) but there was no 337 
change in resting plasma [NO2-] with SIT+PL (P>0.05; Fig. 1B). There were no differences 338 
in the plasma [NO2-] measured at rest between 2 weeks and 4 weeks in any of the groups 339 
(P>0.05).  340 
Blood Pressure  341 
Systolic BP was not different between the groups before the interventions (P>0.05; Table 1) 342 
but there was a significant main effect for time (P<0.05) and an interaction effect (P<0.05). 343 
Post hoc tests revealed that, compared to pre-intervention, systolic BP was reduced at 2 344 
weeks and at 4 weeks (P<0.05) by 5 ± 6 mmHg and 6 ± 4 mmHg in SIT+BR, respectively 345 
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(P<0.05), and by 4 ± 5 mmHg and 10 ± 6 mmHg in NT+BR, respectively (P<0.05), whereas 346 
systolic BP remained unaltered in SIT+PL (P>0.05; Table 1). Diastolic BP was not different 347 
between groups at pre-intervention (P>0.05) and remained unaltered at 2 weeks and at 4 348 
weeks (both P>0.05) in all interventions (Table 1). The MAP was not different between 349 
groups at pre-intervention but there was a significant main effect for time (P<0.05) such that 350 
MAP was reduced by 3 ± 5 mmHg at 4 weeks in both SIT+BR and NT+BR (P<0.05) but was 351 
unchanged with SIT+PL (Table 1). Relative to post-intervention resting baseline, plasma 352 
[NO2-] declined by ~65% at task failure during severe-intensity exercise (P<0.001) in 353 
SIT+BR and NT+BR. The reduction in plasma [NO2-] following 3 min of severe-intensity 354 
exercise was greater in NT+BR compared to SIT+BR (P<0.05).  355 
Incremental exercise test 356 
Peak WR was not different between the groups at pre-intervention (P>0.05; Table 1). There 357 
was a significant main effect by time (P<0.001) and an interaction effect (P<0.05). Post hoc 358 
tests revealed that peak WR was improved at 4 weeks compared to pre-intervention in all 359 
groups (P<0.05; Table 1). However, peak WR increased more from pre- to post-intervention 360 
in SIT+BR than in SIT+PL (P<0.001; Fig. 2). Additionally, peak WR was improved at 2 361 
weeks compared to pre-intervention in SIT+BR only (P<0.05; Fig. 2).  362 
Vሶ O2peak was not different between the groups at pre-intervention (P>0.05; Table 1). There was 363 
a significant main effect by time on Vሶ O2peak (P<0.05). Post hoc analysis revealed that, 364 
compared to pre-intervention, Vሶ O2peak was increased after 2 weeks and 4 weeks with SIT+BR 365 
(P<0.05; Table 1) but remained unchanged in SIT+PL and NT+BR (P>0.05; Table 1). 366 
However, there were no differences between the three groups in the change in Vሶ O2peak from 367 
pre- to post-intervention (P>0.05). There were no significant changes in body mass from pre- 368 
to post-intervention in any of the groups.  369 
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The Vሶ O2 at the GET was not different between the groups at pre-intervention (P>0.05; Table 370 
1) and was not altered by any intervention (P>0.05; Table 1). The WR associated with the 371 
GET was not different between groups at pre-intervention (P>0.05; Table 1). There was a 372 
significant main effect for time such that the WR at the GET was increased pre- to post-373 
intervention in SIT+BR only (P<0.05; Table 1). However, there were no differences between 374 
the three groups in the change in the WR at the GET from pre- to post-intervention (P>0.05). 375 
Step exercise tests: Moderate-intensity exercise 376 
The Vሶ O2 measured during baseline cycling at 20 W preceding the transition to moderate-377 
intensity exercise was not different between groups at pre-intervention (P>0.05; Table 1) and 378 
was not affected by any intervention (P>0.05; Table 1). The end-exercise Vሶ O2 during 379 
moderate-intensity exercise was not different between groups at pre-intervention (P>0.05; 380 
Table 1). There was a significant main effect by time (P<0.05) and an interaction effect 381 
(P<0.05) on end-exercise Vሶ O2. Post hoc analyses revealed that, compared to pre-intervention, 382 
end-exercise Vሶ O2 was significantly reduced in SIT+BR (P<0.05) and NT+BR (P<0.05) but 383 
was unaltered in SIT+PL (P>0.05; Table 1). There was no difference in the change in end-384 
exercise Vሶ O2 from pre- to post-intervention between the SIT+BR and NT+BR groups 385 
(P>0.05). 386 
Step exercise tests: Severe-intensity exercise 387 
The time to task failure during severe-intensity exercise was not different between groups at 388 
pre-intervention (P>0.05; Table 1). There was a significant main effect by time (P<0.05) and 389 
an interaction effect (P<0.05) such that time to task failure was improved by 163 ± 144 s pre- 390 
to post- intervention in SIT+PL (P<0.05; Table 1) and by 170 ± 90 s pre- to post-intervention 391 
in SIT+BR (P<0.05; Table 1) but was unaltered by NT+BR (P>0.05; Table 1). There was no 392 
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difference in the change in the time to task failure from pre- to post-intervention between the 393 
SIT+BR and SIT+PL groups (P>0.05). 394 
Blood [lactate] was not different between groups during severe-intensity exercise at pre-395 
intervention (P>0.05). There was a main effect by time on blood [lactate] (P<0.05). Post-hoc 396 
analysis revealed that blood [lactate] was lower at 1 min (1.2 ± 1.1 mM decrease from same 397 
time point pre-intervention; P<0.05; Fig. 3) and at 3 min (1.6 ± 1.5 mM decrease from same 398 
time point pre-intervention; P<0.05, Fig. 3) during severe-intensity exercise in SIT+BR but 399 
not SIT+PL or NT+BR (P>0.05). Further analyses revealed that the increase in blood 400 
[lactate] from rest to 3 min was attenuated post-intervention compared to pre-intervention  in 401 
SIT+BR (2.7 ± 0.9 vs. 3.9 ± 0.8 mM) (P<0.05). This attenuation was significantly greater 402 
than the equivalent change in blood [lactate] from rest to 3 min in SIT+PL (post-intervention: 403 
4.1 ± 1.9 vs. pre-intervention: 3.7 ± 1.2 mM; P<0.05). 404 
Muscle substrates and metabolites 405 
Pre-intervention values for muscle substrates and metabolites during severe-intensity exercise 406 
were not different between groups (P>0.05) and muscle [ATP] and [PCr] were unchanged by 407 
the interventions in all groups (P>0.05).  408 
There were main effects by time on the muscle [lactate] and pH measured at 3 min of severe-409 
intensity exercise (P<0.05). Post hoc tests revealed that, compared to pre-intervention, 410 
muscle [lactate] was lower and pH was higher at 3 min of severe-intensity exercise post-411 
intervention in SIT+BR (P<0.05; Fig. 4). Further analyses revealed that, compared to pre-412 
intervention, the increase in muscle [lactate] and the decrease in muscle pH from rest to 3 413 
min of exercise tended to be attenuated post-intervention in SIT+ BR (both P=0.09).  414 
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There was a main effect by time on muscle [glycogen] measured at rest, at 3 min and at 415 
exhaustion (all P<0.05). Post hoc tests revealed that, compared to pre-intervention, muscle 416 
[glycogen] was higher at all three time points post-intervention compared to pre-intervention 417 
in SIT+BR (P<0.05; Fig 5). Muscle [glycogen] was also higher at all three time points post-418 
intervention in SIT+BR and SIT+PL compared to NT+BR (P<0.05; Fig 4). There were no 419 
differences between SIT+BR and SIT+PL in the change in muscle [glycogen] from pre- to 420 
post- intervention at rest, 3 min of exercise or at exhaustion (P>0.05). 421 
Muscle fiber type 422 
The relative proportion of type I (SIT+BR: 57 ± 16%; SIT+PL: 59 ± 10%; NT+BR: 48 ± 423 
16%), type IIa (SIT+BR: 36 ± 12%; SIT+PL: 36 ± 16%; NT+BR: 44 ±16%) and type IIx 424 
(SIT+BR: 7 ± 8%; SIT+PL: 5 ± 7%; NT+BR: 8 ± 12%) muscle fibers at pre-intervention 425 
were not different between groups (P>0.05). There was a significant effect of time and an 426 
interaction effect on the proportion of type IIx fibers. Post hoc tests revealed that the 427 
proportion of type IIx fibers identified in SIT+BR was lower post-intervention (4 ± 5%) 428 
compared to pre-intervention (7 ± 8%; P<0.05). In contrast, the proportion of type IIx fibers 429 
identified in SIT+PL tended to be higher post-intervention (10 ± 9%) compared to pre-430 
intervention (5 ± 7%; P=0.07). The change in type IIx fibers was significantly different in 431 
SIT+BR compared to SIT+PL (P<0.05) but not NT+BR (P>0.05). There were no differences 432 
in the proportion of type I (SIT+BR: 55 ± 12%; SIT+PL: 58 ± 10%; NT+BR: 50 ± 17%) or 433 
type IIa (SIT+BR: 41 ± 9%; SIT+PL: 32 ± 16%; NT+BR: 43 ± 14%) muscle fibers following 434 
any intervention (P>0.05). However, there was a significant interaction effect on the 435 
proportion of type I and type IIa fibers combined (type I+IIa; P<0.05). Post hoc tests revealed 436 
that the proportion of type I+IIa fibers identified in SIT+BR was higher post-intervention (96 437 
± 6%) compared to pre-intervention (93 ± 8%; P<0.05). In contrast, the proportion of type 438 
I+IIa fibers identified in SIT+PL tended to be lower post-intervention (90 ± 9%) compared to 439 
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pre-intervention (95 ± 7%; P=0.07). The change in type I+IIa fibers was significantly 440 
different in SIT+BR and NT+BR compared to SIT+PL (P<0.05). 441 
  442 
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Discussion 443 
This is the first study to investigate the combined effect of SIT and NO3- supplementation, 444 
administered in the form of beetroot juice, on muscle metabolic adaptations and the 445 
physiological responses to ramp incremental, moderate-intensity and severe-intensity 446 
exercise performance in normoxia. We compared the effects of chronic NO3- supplementation 447 
alone (NT+BR) with the effects of concurrent NO3--rich (SIT+BR) and NO3--depleted 448 
(SIT+PL) beetroot juice supplementation during a SIT intervention. Consistent with our 449 
hypotheses, the separate 4 week interventions of SIT and chronic BR supplementation 450 
independently induced several beneficial physiological and/or performance effects. However, 451 
the main finding of the present study was that the combination of SIT and BR 452 
supplementation provided greater improvements in incremental exercise performance 453 
compared to either intervention alone and led to greater improvements in some indices of 454 
muscle metabolic adaptation.  455 
Plasma [NO3-] and [NO2-] were elevated, and systolic BP was lowered following 2 weeks and 456 
4 weeks of BR supplementation, changes which are consistent with elevated systemic NO 457 
bioavailability. Interestingly, however, resting plasma [NO3-] and [NO2-] were not altered 458 
following 4 weeks of SIT+PL. Previous studies have reported that subjects with higher 459 
aerobic fitness and/or training status have higher resting plasma [NO3-] and [NO2-] compared 460 
to less fit and/or sedentary subjects (53, 63). The results of the present study may therefore 461 
indicate that short-term SIT, at least when combined with PL supplementation, does not 462 
substantially modify NOS activity or protein expression. The reduction in plasma [NO2-] 463 
from resting baseline to task failure during severe-intensity exercise was similar between 464 
NT+BR and SIT+BR (~65% decline). However, the reduction in plasma [NO2-] from resting 465 
baseline to 3 min of severe-intensity exercise was attenuated in SIT+BR (~25% decline) 466 
compared to NT+BR (~45% decline). It is possible that this may be related to differences in 467 
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training status induced by the separate interventions; for example, less reduction of NO2- to 468 
NO may have been required following SIT+BR due to training-related improvements in 469 
muscle capillarity and oxygenation (18). 470 
 The reductions in systolic BP (SIT+ BR: -4% and -5%, NT+BR: -6% and -9%, at 2 weeks 471 
and 4 weeks, respectively) reported in the present study are similar to those previously 472 
reported in healthy volunteers following shorter supplementation periods (5, 44, 73, 74). 473 
Diastolic BP was unaltered in NT+BR and SIT+PL but was reduced by 7% in SIT+BR. MAP 474 
was lowered by ~4% in both NO3- supplemented groups (SIT+BR and NT+BR), but was 475 
unaltered in SIT+PL. Collectively, these data indicate that 4 weeks of NO3- supplementation 476 
may result in a greater reduction in BP than 4 weeks of SIT alone. 477 
The effect of SIT and BR on sub-maximal Vሶ O2 and Vሶ O2peak 478 
A high exercise economy, i.e. a low Vሶ O2 for a given power output, is an important 479 
determinant of exercise performance (33). It has been postulated that exercise training can 480 
lower the O2 cost of submaximal cycling (55). However, in the present study, the O2 cost of 481 
moderate-intensity exercise was only reduced following training in SIT+BR and the 482 
magnitude of the reduction in the O2 cost of exercise was not different to that observed with 483 
NT+BR, suggesting that 4 weeks of SIT per se has no influence on the O2 cost of submaximal 484 
cycling. This finding is consistent with previous work indicating that the O2 cost of exercise 485 
may be reduced by dietary NO3- supplementation (5, 45, 46, 73). The physiological bases for 486 
the improved efficiency following NO3- ingestion are likely related to a reduced ATP cost of 487 
muscle force production (6) and/or a reduced O2 cost of mitochondrial ATP resynthesis (46, 488 
cf. 76).  489 
Despite the low training volume, SIT has emerged as a potent strategy to increase aerobic 490 
capacity and endurance exercise performance in as little as two weeks (11, 65, 70). We found 491 
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that Vሶ O2peak was not significantly altered by 4 weeks of either NT+BR or SIT+PL. The 492 
former result is consistent with the majority of studies that have assessed Vሶ O2peak following 493 
acute or short-term NO3- supplementation (5, 6, 39, 45, 78).  The lack of effect of SIT on 494 
Vሶ O2peak.is also consistent with some (11, 12, 13, 26), but not all (65, 70), previous 495 
investigations. The physiological and muscle metabolic adaptations to SIT are likely 496 
dependent upon the initial training status of the subjects along with the exact nature of the 497 
training stimulus, including the frequency and duration of both the sprint and recovery 498 
periods (66). In this respect, it is important to highlight that our exercise training protocol 499 
was shorter in duration to some studies (13) and the progression in training volume was more 500 
gradual than in other studies (4, 65) in which Vሶ O2peak was increased.  501 
 Although the change in Vሶ O2peak from pre- to post-intervention was not different between the 502 
three groups, the increase in Vሶ O2peak was only greater from pre- to post intervention in 503 
SIT+BR, suggesting that NO3- supplementation may enhance the adaptation of Vሶ O2peak to 504 
SIT. Further work is required to confirm this observation and to elucidate the potential 505 
cardiovascular and/or metabolic mechanisms which may be responsible.  506 
The effect of SIT and BR on exercise performance 507 
The peak WR during incremental exercise at 4 weeks was improved in both training groups. 508 
Interestingly, peak WR was also significantly improved following NT+BR. Although this 509 
effect was small, it is consistent with an earlier study which reported a significant increase in 510 
peak WR during incremental exercise following 15 days BR supplementation (73). 511 
Interestingly, a greater peak WR at 2 weeks of training was only observed with SIT+BR. 512 
Moreover, the improvement in peak WR at 4 weeks was greater in SIT+BR than in SIT+PL 513 
and NT+BR. The greater, and more rapidly attained, improvements in incremental exercise 514 
test performance with SIT+BR is presumably a function of the improved exercise economy 515 
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and/or favorable muscle metabolic profile which would be expected to result in an extended 516 
time to reach Vሶ O2peak. Our results are consistent with a recent study by Muggeridge et al. (57) 517 
which reported that 3 weeks of SIT (4-6 repeated 15-s sprints) increased peak WR during 518 
incremental exercise to a greater extent when subjects were supplemented with NO3- 519 
compared to placebo.  520 
The time to task failure during severe-intensity exercise was significantly increased after 4 521 
weeks of both SIT+BR (group mean change: +69%) and SIT+PL (+55%), but not NT+BR 522 
(+3%). Despite evidence for an enhanced muscle metabolic response to severe-intensity 523 
exercise in SIT+BR compared to SIT+PL (see below), this did not translate into a greater 524 
improvement in severe-intensity exercise performance. It is not clear why this was the case 525 
nor why ramp incremental exercise test performance was improved with SIT+BR when time 526 
to task failure during severe-intensity exercise was not, although greater variability in time-527 
to-exhaustion tests may have contributed to the difference (20). Indeed, it is interesting to 528 
note that the improvement in time to task failure ranged from 37-116% in SIT+BR (with 9/12 529 
subjects improving by more than 50%) and from 4-122% in SIT+PL (with 4/12 subjects 530 
improving by more than 50%). Our results are similar to those of Puype et al. (64) who found 531 
that 6 weeks of endurance training in normobaric hypoxia with BR supplementation did not 532 
improve 30-min time trial performance relative to the placebo condition. However, it remains 533 
unclear whether BR supplementation during training could improve performance in other 534 
types of exercise. Recent studies indicate that BR may be ergogenic during high-intensity 535 
intermittent exercise (2, 71, 78) and that, compared to placebo, NO3- supplementation during 536 
SIT improves fatigue resistance during repeated sprint exercise (57) and may enhance mean 537 
power output in a 30 s sprint (21). Further studies are required to investigate whether the 538 
subtle enhancements of skeletal muscle adaptation to training with BR might translate into 539 
improved performance during these other forms of exercise. 540 
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The effect of SIT and BR on the muscle metabolic response to exercise 542 
Although conflicting data exist, SIT has been implicated in rapid skeletal muscle remodeling 543 
(11, 12, 13, 26). The extreme perturbations in substrate availability and metabolite 544 
accumulation caused by repeated sprint efforts require substantial oxidative energy turnover 545 
to restore homeostasis (8). The fluctuations in ATP availability and local O2 tension are 546 
potent stimulators of signaling pathways and may induce mitochondrial biogenesis and 547 
oxidative enzyme adaptation via the transcription of PGC-1α (28, 31, 50). Recent findings 548 
indicate that dietary NO3- may favorably affect the contractility (30, 32) and perfusion (22, 549 
23) of type II muscle fibers, and reduce the energetic cost of muscle force production during 550 
high-intensity exercise (6, 24). Similar to SIT (3, 13, 47, 48, 49, 61, 62), elevating NO2- and 551 
NO bioavailability with chronic NO3--rich BR supplementation may also stimulate the 552 
transcription of PGC-1α (43, 54, 58), a key regulator of mitochondrial biogenesis (77) and 553 
angiogenesis (1, 15). We therefore determined the effects of 4 weeks SIT and 4 weeks BR 554 
supplementation on the muscle metabolic responses during exercise and tested the hypothesis 555 
that these adaptations may be amplified when the interventions were combined. 556 
There were no differences in muscle [ATP], [PCr], [lactate] or pH at rest or at task failure 557 
during severe-intensity exercise, post-intervention compared to pre-intervention, in any 558 
group. However, at 3 min into severe-intensity exercise, there was evidence of reduced 559 
metabolic perturbation, post-intervention compared to pre-intervention, in the SIT+BR group 560 
only. Specifically, muscle [lactate] as well as blood [lactate] was lower, and muscle pH was 561 
higher, at 3 min of severe-intensity exercise following SIT+BR but not SIT+PL or NT+BR 562 
(Figs. 3 and 4), suggesting an enhanced muscle metabolic adaptation to SIT when combined 563 
with BR supplementation.  564 
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The reason for the small difference in muscle acidosis at the 3 min exercise iso-time with 565 
SIT+BR compared to SIT+PL is unclear. However, this may be the result of differences in 566 
exercise efficiency between the training groups. The lower O2 cost of exercise measured at 567 
the same submaximal work rate in SIT+BR would be expected to lower the physiological 568 
strain and potentially reduce substrate-level phosphorylation and lactate production during 569 
exercise (34). Furthermore, BR supplementation has been shown to elevate microvascular 570 
PO2 in type II muscles of exercising rats thus promoting O2 exchange between the capillary 571 
and the myocyte and enabling a better preservation of intramuscular homeostasis (22, 23). By 572 
better maintaining oxidative function, this mechanism may be important in delaying lactate 573 
accumulation during severe-intensity exercise which is known to mandate an increased 574 
recruitment of type II fibers to sustain power output (42). While NO3- intake alone would be 575 
expected to promote some of these effects (for example, a lower O2 cost of sub-maximal 576 
exercise in the NT+BR group in the present study), NO3- intake combined with training may 577 
synergistically improve the muscle metabolic response to severe-intensity exercise. In 578 
particular, the SIT+BR group evidenced improved exercise efficiency (which was observed 579 
with NT+BR but not SIT+PL) and improved performance and physiological 580 
responses/adaptations to maximal exercise (which were observed with SIT+PL but to a much 581 
lesser extent with NT+BR).    582 
None of the interventions influenced the proportion of type I muscle fibers identified 583 
following training. Interestingly, there was a disparity in the muscle phenotypic response to 584 
training between SIT+BR and SIT+PL. Specifically, SIT+BR resulted in a significant 585 
reduction in the proportion of type IIx muscle fibers. In contrast, SIT+PL resulted in a trend 586 
towards a greater proportion of type IIx fibers following the intervention period. These results 587 
suggest that a remodeling of skeletal muscle towards a more oxidative phenotype following 588 
SIT (26, 27) may be facilitated by BR supplementation and perhaps hampered by PL 589 
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supplementation. Our findings are consistent with a recent study which also reported changes 590 
in muscle fiber type composition following 5 weeks of SIT with ~5 mmol daily NO3- 591 
supplementation (21). These authors reported that SIT performed in hypoxia resulted in a 592 
significant increase in the relative number of type IIa fibers in the m. vastus lateralis (from 593 
~45 to 56%) when subjects ingested NO3- compared to placebo. It is possible that the 594 
differences in the muscle metabolic or performance response to exercise following SIT when 595 
combined with NO3- compared to placebo supplementation (present study; 57) are related to 596 
changes in muscle fiber type composition – i.e., a greater reduction in type IIx fibers and/or a 597 
greater increase in type IIa fibers (present study; 21).     598 
It is important to highlight that both the BR and PL supplements contain high concentrations 599 
of antioxidants including betacyacins and polyphenols (38, 67) which may potentially 600 
interfere with skeletal muscle adaptations to training (56, 60). It is possible, therefore, that the 601 
adaptations to training in the SIT+PL group were attenuated in the present study due to the 602 
simultaneous intake of antioxidants. However, it is also possible that the potential for chronic 603 
NO3- administration to enhance muscular adaptations and exercise performance with SIT was 604 
underestimated in the SIT+BR group for the same reason. On the other hand, it has recently 605 
been reported that BR supplementation increases hydrogen peroxide emission from the 606 
mitochondria, an effect that could promote redox signaling (76) and enhance training 607 
adaptations. Moreover, the combination of NO3- with antioxidants might promote the 608 
reduction of NO2- to NO and facilitate physiological effects (36).  Further research should 609 
investigate the influence of NO3- alone (as NaNO3 or KNO3) and BR on the skeletal muscle 610 
adaptations to training. Our study design involved 4 weeks of daily BR supplementation with 611 
the final dose being consumed on the morning of the post-intervention laboratory tests. Our 612 
measurements therefore reflect the combined effects of chronic and acute BR (or PL) 613 
supplementation superimposed on exercise training. It has been reported recently that 4 614 
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weeks of BR supplementation continues to exert physiological effects for at least 48 hours 615 
following the cessation of supplementation (80). Future studies might therefore be designed 616 
to partition out the influence of chronic NO3- or BR supplementation (without additional 617 
acute supplementation) on the adaptations to training. 618 
Conclusions 619 
In the absence of training, chronic BR ingestion resulted in a significant reduction in the O2 620 
cost of moderate-intensity exercise and a small but significant increase in peak WR. SIT+PL 621 
resulted in improvements in peak WR during incremental exercise and time to task failure 622 
during severe-intensity exercise. Greater changes in peak WR during incremental exercise 623 
were found with SIT+BR compared to SIT+PL and NT+BR. In addition, type IIx muscle 624 
fiber proportion was reduced and, at the 3-min iso-time during severe-intensity exercise, 625 
muscle pH was higher and muscle (and blood) [lactate] was lower in SIT+BR only. These 626 
findings suggest that the independent physiological and performance effects of SIT and BR 627 
supplementation may be enhanced when these interventions are combined. Dietary NO3- 628 
supplementation in the form of BR may potentiate some exercise performance and muscle 629 
metabolic adaptations to SIT. 630 
 631 
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Figure Legends 890 
Figure 1. Mean ± SD resting plasma [NO3-] (panel A) and plasma [NO2-] (panel B) responses 891 
in SIT+BR (solid black line), SIT+PL (solid grey line) and NT+BR (dotted black line). * = 892 
different from pre-intervention (P<0.05); † = different from mid-intervention (P<0.05); ‡ = 893 
different from SIT+PL (P<0.05). 894 
Figure 2. Mean ± SD changes (∆) in peak WR at mid- and post-intervention in the three 895 
groups expressed relative to pre-intervention baseline. The change in peak WR from pre- to 896 
post-intervention was greater in SIT+BR (solid black line) than SIT+PL (solid grey line) and 897 
NT+BR (dotted black line). * = different from pre-intervention (P<0.05), † = different from 898 
mid-intervention (P<0.05), # = different from NT+BR (P<0.05), ‡ = different from SIT+PL 899 
(P<0.05).  900 
Figure 3. Mean ± SD blood [lactate] at rest (black bars), 1 min (patterned bars), 3 min (grey 901 
bars) and at task failure (open bars) during severe-intensity exercise. * = different to pre-902 
intervention (P<0.05).  903 
Figure 4. Mean ± SD muscle [lactate] (panel A), muscle pH (panel B) and muscle [glycogen] 904 
(panel C) at rest (black bars), 3 min (grey bars) and at task failure (open bars) during severe-905 
intensity exercise. * = different to pre-intervention (P<0.05); # = different to post-906 
intervention NT+BR (P<0.05); ‡ = different to post-intervention SIT+PL (P<0.05).  907 
 908 
Table 1. Physiological and performance variables pre-, mid- and post-intervention 
  SIT+PL    SIT+BR    NT+BR  
 Pre Mid Post  Pre Mid Post  Pre Mid Post 
Blood pressure            
   SBP 
   (mmHg) 
116 ± 13 115 ± 14 116 ± 10  118 ± 11 113 ± 11* 112 ± 10*‡  117 ± 13 113 ± 10* 107 ± 17*‡ 
   DBP 
   (mmHg) 
67 ± 8 64 ± 7 66 ± 4  67 ± 9 64 ± 9 62 ± 7  63 ± 5 63 ± 7 62 ± 8 
   MAP 
   (mmHg) 
83 ± 8 81 ± 8 83 ± 6  84 ± 8 80 ± 9 79 ± 7*  82 ± 7 80 ± 7 77 ± 7* 
Incremental test  
 
          
   Peak WR 
   (W) 
303 ± 78 306  ± 72 318 ± 73*†  298 ± 93 305 ± 90* 321 ± 91*†  296 ± 66 295 ± 67 300 ± 67* 
   ∆ Peak WR 
   (W) 
- 4 ± 13 16 ± 15*†#  - 7 ± 10*# 24 ± 8*†#‡  - 0 ± 9 4 ± 4* 
   ܄ሶ O2 peak 
   (L·min-1) 
3.43 ± 0.99 3.49 ± 0.97 3.50 ± 0.86  3.19 ± 1.03 3.39 ± 1.06* 3.47 ± 1.02*  3.28 ± 1.03 3.42 ± 0.99 3.42 ± 1.08 
 
 
   ܄ሶ O2 at GET 
   (L·min-1) 
1.55 ± 0.49 1.49 ± 0.41 1.62 ± 0.44  1.60 ± 0.37 1.58 ± 0.37 1.64 ± 0.43  1.61 ± 0.46 1.62 ± 0.52 1.61 ± 0.4 
   WR at GET 
   (W) 
 
 
110 ± 32 103 ± 34 112 ± 27  102 ± 30 
 
105 ± 32 110 ± 27*  105 ± 34 102 ± 29 112 ±  27 
Moderate-intensity exercise            
   End-exercise ܄ሶ O2 
   (L·min-1) 
1.57 ± 0.41 - 1.67 ± 0.44  1.64 ± 0.41  - 1.58 ± 0.42*‡  1.73 ± 0.32 - 1.65 ± 0.34*‡ 
Severe-intensity exercise            
   Time to task failure 
   (s) 
297 ± 69 - 460 ± 186*#  248 ± 53 - 418 ± 132*#  266 ± 82 - 275 ± 84 
 
Values are means ± SD. SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; Vሶ O2, oxygen uptake; Vሶ O2 peak, peak Vሶ O2; WR, work rate; 
GET, gas exchange threshold; SIT+BR, high-intensity interval training plus NO3--rich beetroot juice; SIT+PL, high-intensity interval training plus NO3--depleted juice; 
NT+BR, no-training plus NO3--rich beetroot juice. * = different from Pre-intervention (P<0.05), † = different from Mid-intervention (P<0.05), # = different from NT+BR 
(P<0.05), ‡ = different from SIT+PL( P<0.05). 
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